Suven Pharmaceuticals Fact Sheet, Suven Pharmaceuticals Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Pharmaceuticals Fact Sheet    (SUVP)


Find Out: How to Profit from 21st Century's BIGGEST Revolution


Here is the latest financial fact sheet of Suven Pharmaceuticals. For more details, see the Suven Pharmaceuticals quarterly results and Suven Pharmaceuticals share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN PHARMACEUTICALS Price History

Price Rs 524.8
Mkt Cap Rs m 133,583
Vol '000 13.1
P/E X 43.3
P/CF X 39.3
EPS (TTM) Rs 12.1
% ch % -1.4
No. of shares m 254.57
% ch week % -3.4
% ch 1-mth % 0.7
% ch 12-mth % 53.4
52 week H/L Rs 589.8/292.0
(As on Oct 19, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN PHARMACEUTICALS Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SUVEN PHARMACEUTICALS EQUITY SHARE DATA
High RsNA353525 
Low RsNA174103 
Sales per share (Unadj.) RsNM65.539.7 
Earnings per share (Unadj.) RsNM21.112.1 
Diluted earnings per shareRsNM10.612.1 
Cash flow per share (Unadj.) RsNM23.013.4 
Dividends per share (Unadj.) Rs05.002.00 
Adj. dividends per shareRs0.002.502.00 
Avg Dividend yield %NM1.90.6 
Book value per share (Unadj.) RsNM66.446.4 
Adj. book value per shareRsNM33.246.4 
Shares outstanding (eoy) m0127.28254.57 
Bonus / Rights / Conversions  --- 
Price / Sales ratio x04.07.9 
Avg P/E ratio x012.525.9 
P/CF ratio (eoy) x011.523.5 
Price / Book Value ratio x04.06.8 
Dividend payout %023.716.5 
Avg Mkt Cap Rs m033,53379,953 
No. of employees `000NANANA 
Total wages/salary Rs m296651762 
Avg. sales/employee Rs ThNMNMNM 
Avg. wages/employee Rs ThNMNMNM 
Avg. net profit/employee Rs ThNMNMNM 
SUVEN PHARMACEUTICALS INCOME DATA
Net Sales Rs m3,7788,33810,097 
Other income Rs m6181142 
Total revenues Rs m3,7848,51910,240 
Gross profit Rs m1,7163,8484,430 
Depreciation Rs m115235316 
Interest Rs m28231117 
Profit before tax Rs m1,5793,5634,139 
Minority Interest Rs m000 
Prior Period Items Rs m000 
Extraordinary Inc (Exp) Rs m000 
Tax Rs m4868751,053 
Profit after tax Rs m1,0932,6883,086 
Gross profit margin %45.446.143.9 
Effective tax rate %30.824.625.4 
Net profit margin %28.932.230.6 
SUVEN PHARMACEUTICALS BALANCE SHEET DATA
Current assets Rs m4,2285,1116,665 
Current liabilities Rs m1,9073,1983,215 
Net working cap to sales %61.422.934.2 
Current ratio x2.21.62.1 
Inventory Days Days18155200 
Debtors Days Days142513370 
Net fixed assets Rs m3,9337,8129,097 
Share capital Rs m0127255 
"Free" reserves Rs m5,7768,32011,554 
Net worth Rs m5,7768,44811,808 
Long term debt Rs m0913356 
Total assets Rs m8,16112,92315,762 
Interest coverage x57.616.436.5 
Debt to equity ratio x00.10 
Sales to assets ratio x0.50.60.6 
Return on assets %13.722.620.3 
Return on equity %18.931.826.1 
Return on capital %27.840.535.0 
Exports to sales %000 
Imports to sales %000 
Exports (fob) Rs m000 
Imports (cif) Rs m000 
Fx inflow Rs m01,4819,902 
Fx outflow Rs m08,9871,369 
Net fx Rs m0-7,5068,533 
SUVEN PHARMACEUTICALS CASH FLOW
From Operations Rs m 504 4,069 3,834 
From Investments Rs m -655 -4,134 -3,114 
From Financial Activity Rs m 260 73 -766 
Net Cashflow Rs m 109 8 -45 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 60.0%
Institution 13.8%
Non-Institution 26.2%
Total 100.0%
Free Float 40.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF #8-2-334 I S D E Serene Chambers, 6th Floor Road No. 5, Avenue 7 Banjara Hills, Hyderabad - 500034
E-MAIL info@suvenpharm.com WEB www.suvenpharm.com
TEL 040 - 2354 9414/ 3311/ 3315 FAX 040 - 2354 1152
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 2018 BSE CODE: 543064 FV (Rs): 1 DIV YIELD (%): 0.4

Read: SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ARTEMIS MEDICARE SERVICES  ZOTA HEALTH CARE  SANJIVANI PA  BLISS GVS PHARMA  ZENITH HEALTH  

Compare SUVEN PHARMACEUTICALS With:   ARTEMIS MEDICARE SERVICES  ZOTA HEALTH CARE  SANJIVANI PA  BLISS GVS PHARMA  ZENITH HEALTH  




Today's Market

Sensex Snaps 7-Day Winning Streak, Nifty Falls Below 18,450; ITC Dips 6%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 8-QTR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS